Serial 97099723
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Dec 2023)
What this means for you
This application is over — abandoned 18 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97099723
- Mark type
- Design / logo
- Filed
- 29 Oct 2021
- Published for opposition
- 21 Mar 2023
- Abandoned
- 18 Dec 2023
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 042 — Scientific and technological services: Development of new treatments in the nature of development for biopharmaceuticals for the treatment of pathologies related to vascular disease; research and development of pharmaceutical preparations and medicines; medical and scientific research services in the fields of inflammation, immuno-inflammatory, chronic diseases such as rheumatoid arthritis (RA), psoriasis, inflammatory bowel disease (IBD), multiple sclerosis (MS), and atherosclerosis, cardio vascular medicine, angiogenesis, vascular disruptive, cancer treatment and diagnosis; medical and scientific research, namely, conducting clinical trials for others; medical research; pharmaceutical drug development services; biopharmaceutical product evaluation; biopharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Vascular Biogenics Ltd., Modiin, IL
- Vascular Biogenics Ltd., Modiin, IL
Prosecution history
- 18 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 16 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Mar 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Mar 2023 — PUBLISHED FOR OPPOSITION
- 01 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Feb 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Feb 2023 — EXAMINER'S AMENDMENT ENTERED
- 14 Feb 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Feb 2023 — EXAMINERS AMENDMENT E-MAILED
- 14 Feb 2023 — EXAMINERS AMENDMENT -WRITTEN
- 15 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Aug 2022 — NON-FINAL ACTION E-MAILED
- 15 Aug 2022 — NON-FINAL ACTION WRITTEN
- 08 Aug 2022 — ASSIGNED TO EXAMINER